Cardiac inflammation, a condition characterized by inflammation of the heart tissue, plays a significant role in various cardiovascular diseases. This inflammatory response can be triggered by infections, autoimmune disorders, or other underlying health issues. When the heart becomes inflamed, it may lead to serious complications, affecting the organ's ability to pump blood effectively. Conditions such as myocarditis and pericarditis are common manifestations of cardiac inflammation, posing risks of heart failure if left untreated. Researchers and healthcare professionals are actively exploring the intricate mechanisms of cardiac inflammation to develop targeted interventions and preventive measures. Understanding and addressing cardiac inflammation are crucial steps in advancing cardiovascular health and mitigating the impact of related diseases on individuals worldwide.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India